Abstract:Two fluorescent nanomedicines based on small molecular cyanine–platinum conjugates have been prepared via a nanoprecipitation method and characterized by transmission electron microscopy (TEM) as well as dynamic light scattering (DLS). The conjugates exhibited an enhanced fluorescence in their nanoparticle formulation compared to that in solution. The nanomedicines could be endocytosed by cancer cells as revealed by confocal laser scanning microscopy (CLSM) and showed high cellular proliferation inhibition. Fluorescent platinum nanomedicines prepared directly from small molecules could be an alternative strategy for developing new drugs with simultaneous cellular imaging and cancer therapy functions. Platinum compounds have emerged as powerful anticancer drugs for decades against many solid malignancies, like ovarian, bladder, head and neck, testicular and lung cancers. Platinum drugs, cisplatin and carboplatin, alone or in combination with other drugs, are used to treat 40–80 % of cancer patients. 7] These drugs have severe side effects, such as hepatotoxicity, nephrotoxicity, cardiotoxicity, gastrointestinal dysfunction, and ototoxicity. Therefore, there is a growing demand for balancing toxicity and efficacy issues of platinum drug. Furthermore, it is difficult to image the distribution and metabolism of platinum drugs in living cells because most of them are not fluorescent and cannot be easily detected. Although fluorescent platinum compounds have been previously reported by using fluorescein derivatives as the fluorophore or by using BODIPY (1,3,5,7-tetramethyl-8-(4-pyridyl)-4,4’-difluorobora diazaindacene) as the fluorescent reporter, they are still unable to avoid the side effects of free drugs, such as rapid clearance in vivo. Compared with free drugs, nanomedicines offer an opportunity to increase the water solubility and to accumulate within solid tumors preferentially due to the enhanced permeability and retention (EPR) effect, thus reducing off-target toxicity and improving the therapeutic index. Among various forms of nanomedicines, polymeric micellar nanoparticles made from amphiphilic copolymer materials such as poly(ethylene glycol)block-poly(D,L-lactic acid) (PEG-PLA) are one of the most widely used drug-delivery platforms. 20–24] However, the low drug loading and the potential toxicity of carriers are major drawbacks in translational medicine. On the other hand, many chemotherapeutic agents are often incompatible with the carriers, such as platinum drugs, resulting in limited entrapment efficiency and suboptimal release kinetics. Even so, more and more multifunctional delivery materials have been developed, but little attention has been paid to finetuning the chemical structures of these drugs to make them compatible with ideal polymeric nanocarriers or to even make nanomedicines by themselves. Recently, nanomedicines prepared directly from small organic molecules without using of drug carriers have drawn much more attentions. Amphiphilic constructs were realized by coupling a hydrophobic compound with hydrophilic antitumor drugs such as gemcitabine and doxorubicin or by conjugating hydrophobic drugs with oligo(ethylene glycol). High drug loading contents and nanoscale particles could be obtained simultaneously. To the best of our knowledge, no small molecular platinum drug has been reported to directly form nanomedicine. Cyanine lead structures are very useful as fluorescence sensing or imaging probes because of their fluorescence enhancement property upon being bound or enclosed in a hydrophobic environment, which is due to the reduction in nonradiative decay caused by restricted torsional rotation in the excited state. In this work, two cyanine–platinum conjugates (CPCs) were synthesized, and fluorescent platinum nanomedicines (FPNMs) were prepared by the self-assembly of CPCs in aqueous solution. CPCs exhibited distinct absorption and photoluminescence (PL) properties in solution and in assembled states. FPNMs could be internalized by cancer cells and showed high cellular proliferation inhibition against human cervical carcinoma (HeLa) and human breast cancer (MCF-7) cells. The synthetic route of (E)-4-(2-(1H-indol-3-yl)vinyl)-pyridine (HIP)–platinum conjugate (HIP-Pt) and (E)-4-(2-(1-methyl-1Hindol-3-yl)vinyl)-pyridine (MIP)–platinum conjugate (MIP-Pt) is [a] Dr. T. Sun, Dr. Z. Li, Prof. Z. Xie, Prof. X. Jing State Key Laboratory of Polymer Physics and Chemistry Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 (China) E-mail : xiez@ciac.ac.cn [b] Dr. T. Sun University of Chinese Academy of Sciences Beijing 100049 (China) Supporting information for this article is available on the WWW under http ://dx.doi.org/10.1002/asia.201501163. Chem. Asian J. 2016, 11, 221 – 225 Ó 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 221 Communication DOI: 10.1002/asia.201501163

Drug Design Amphiphilic Cyanine – Platinum Conjugates as Fluorescent